Magnitude of Hepatitis-B in India: Role of Hepatitis B Vaccination
Keywords:
Hepatitis B, Vaccination, Chronic carrier, Prevalence of Hepatitis BAbstract
Hepatitis B Infection is most prevalent chronic infection in India. It is associated with Hepatocellular carcinoma in chronic carrier. It is also responsible for chronic hepatitis and hepatic failure in large number of population. It is almost more than a decade Hepatitis B vaccination was included in National Immunization Programme (NIP). Still hepatitis B continues to be a major health Issue. In this review article we have discussed about role of vaccination in Hepatitis B infection in Indian scenario.
References
Dhamdhere MR, Nadkarni MG. Infectious hepatitis at Aurangabad. Report of an outbreak. Indian J Med Sci 1962 Dec; 16:1006–15.
Bhattacharji LM, Saha AL, Sampathkumaran MA, De SK. Investigation of an outbreak of infectious hepatitis in a small town in West Bengal during July–October, 1960. Indian J Med Res. 1963 May; 51:550–62.
Pattanayak S, Singha P, Pal SC, Rao CK, Shrivastav JB. An outbreak of infectious hepatitis in Siliguri, 1966. Indian J Med Res 1968 Nov; 56(11):1605–16.
Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 1992; 70(5):597–604.
Ray R, Aggarwal R, Salunke PN, Mehrotra NN, Talwar GP, Naik SR. Hepatitis E virus genome in stools of hepatitis patients during large epidemic in north India. Lancet 1991Sep; 338(8770):783–4.
Nanda SK, Yalcinkaya K, Panigrahi AK, Acharya SK, Jameel S, Panda SK. Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol 1994 Feb; 42(2):133–7.
Acharya SK, Panda SK, Saxena A, Gupta SD. Acute hepatic failure in India: A perspective from the East. J Gastroenterol Hepatol.2000 May; 15(5):473–9.
Hillis WD, Pattanayak S, Arora DD. Detection of Australia antigen in human viral hepatitis. Indian J Med Res. 1970 Sep; 58(9):1172–6.
Sama SK, Anand S, Malaviya AN, Gandhi PC, Tandon BN. Australia-SH antigen in normal population and patients of viral hepatitis in Delhi. Indian J Med Res 1971; 59:64–8.
Pal SR, Dutta DV, Choudhury S, Jolly JG, Deodhar SD, Samant AK, et al. Serum hepatitis (SH) antigen amongst patients with liver diseases and voluntary blood donors—A prospective study. Indian J Med Res 1973; 61:1784–98.
Sama SK, Sarla PK, Gera KL. Hepatitis associated antigen amongst blood donors in Delhi by counterelectrophoresis. Indian J Med Res 1973; 61:406–10.
Shanmugham RV, John TJ, Hill PG, Carman RH. Comparative sensitivity of cross-over electrophoresis and complement fixation test for the detection of Australia antigen. Indian J Med Res 1973; 61:521–4.
Dutta RN, Mahammed GS. Incidence of Australia antigen in voluntary and professional blood donors and also in cases of viral hepatitis. Indian J Med Res 1972; 60:1774–8.
Singhvi A, Pulimood RB, John TJ, Babu PG, Samuel BU, Padankatti T, et al. The prevalence of markers for hepatitis B and human immunodeficiency viruses, malarial parasites and microfilaria in blood donors in a large hospital in south India. J Trop Med Hyg 1990; 93:178–82.
Elavia AJ, Banker DD. Prevalence of hepatitis B surface antigen and its subtypes in high risk group subjects and voluntary blood donors in Bombay. Indian J Med Res 1991; 93:280–5.
Irshad M, Joshi YK, Acharya SK, Tandon BN. Prevalence of hepatitis B virus infection in healthy persons in North India. Natl Med J India 1994; 7:210–12.
Nijhawan S, Rai RR, Sharma D, Saxena HB. HBsAg prevalence in blood donors in Jaipur. Indian J Gastroenterol 1997; 16:162
Chowdhury A, Santra A, Chakravorty R, Banerji A, al S, Dhali GK, et al. Community based epidemiology of hepatitis B virus infection in West Bengal, India: Prevalence of hepatitis B e antigen negative infection and associated viral variants. J Gastroenterol Hepatol 2005; 20:1712–20
Sehgal A, Gupta I, Sehgal R, Ganguly NK. Hepatitis B vaccine alone or in combination with anti-HBs immunoglobulin in the perinatal prophylaxis of babies born to HBsAg carrier mothers. Acta Virol. 1992 Aug; 36(4):359–66.
Gill HH, Majumdar PD, Dhunjibhoy KR, Desai HG. Prevalence of hepatitis B e antigen in pregnant women and patients with liver disease. J Assoc Physicians India. 1995 Apr; 43(4):247–8.
Prakash C, Sharma RS, Bhatia R, Verghese T, Datta KK. Prevalence in North India of hepatitis B carrier state amongst pregnant women. Southeast Asian J Trop Med Public Health 1998; 29:80–4.
Phadke A, Kale A. HBV carrier rate in India. Indian Pediatr 2002; 39:787–8.
Mital MK, Vij JC, Talukdar B, Sachdev HP, Saini L. Prevalence of hepatitis-B virus markers in multitransfused thalassemic patients. Indian Pediatr 1988; 25:161–5.
Choudhry VP, Acharya SK. Hepatitis B, C and D viral markers in multitransfused thalassemic children: Longterm complications and present management. Indian J Pediatr 1995; 62:655–68.
Jaiswal SP, Chitnis DS, Jain AK, Inamdar S, Porwal A, Jain SC. Prevalence of hepatitis viruses among multitransfused homogenous thalassaemia patients. Hepatol Res 2001; 19:247–53.
Irshad M. Singh YN, Acharya SK. HBV-status in professional blood donors in North India. Trop Gastroenterol. 1992; 13:112–14.
Duseja A, Arora L, Masih B, Singh H, Gupta A, Behera D, et al. Hepatitis B and C virus––prevalence and prevention in health care workers. Trop Gastroenterol 2002; 23:125–6.
Ganju SA, Goel A. Prevalence of HBV and HCV infection among health care workers (HCWs). J Commun Dis 2000; 32:228–30.
Sarkar K, Ganguly DN, Baisali B, Saha MK, Bhattacharya SK. Hepatitis B infection, Estern India. Emerg Infect Dis. 2004 Jul; 10(7):1341-2.
Thakur V, Kazim SN, Guptan RC, Malhotra V, Sarin SK. Molecular epidemiology and transmission of hepatitis B virus in close family contacts of HBV-related chronic liver disease patients. J Med Virol 2003; 70:520–8.
Kar P, Mukhopadhyay S, Gopalkrishna V, Das BC. Infection with hepatitis G-virus and viral hepatitis in India. Curr Sci. 2000; 7:189-94.
Assad S, Francis A. Over a decade of experience with a yeast recombinant hepatitis B vaccine. Vaccine. 1999; 18:57-67.
Venters C, Graham W, Cassidy W. Recombivax-HB: perspectives past, present and future. Expert Rev Vaccines. 2004; 3:119-29.
Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP,finelli L et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep. 2006; 55:1-33. Quiz CE1-4.
Gomber S, Sharma R, Ramachandran VG, Talwar V, and Singh B. Immunogenicity of Hepatitis B Vaccine Incorporated into the Expanded Program of Immunization Schedule. Indian Pediatrics 2000; 37: 411-3.
Coberly JS, Townsend T, Repke J, Fields H, MargolisH, Halsey NA. Suboptimal response following intradermal hepatitis B vaccine in infants. Vaccine 1994; 12: 984-987.
Stevens CE, Toy PT, Taylor PE, Lee T, YipH. Prospects for control of hepatitis B virus infection: Implications of childhood vaccination and longterm protection. Pediatrics 1992; 90: 170-173
Giammanco G, Moiraghi A, Zotti C, Pignato S, Volti Li S, Giammanco A, et al. Safety and immunogenicity of a combined diphteria-tetanus-acellular pertusis-hepatitis B vaccine administered according to two different primary vaccination schedules. Vaccine 1998; 16: 722-726.
Safary A. Hepatitis B vaccination - Now and in the future. In: Hepatitis-B in India: Problems and Prevention. Eds. Sarin SK, Singhal AK. New Delhi, CBS Publishers, 1996; pp 132-151.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Biomedical Review follows the Creative Commons CC-BY license (Attribution). It means Authors can use, reuse and build upon the material published in the journal but only for non-commercial purposes. Every article published in the Journal clearly mentioned licensing terms between author/authors and publisher (Siddharth Health Research and Social Welfare Society) as the logo of Creative Commons CC-BY license (Attribution) https://creativecommons.org/licenses/by/4.0/.